Rheumatology 1999; 38: 1171-1174
© 1999 British Society for Rheumatology
Editorials |
Behçet's syndrome
The Royal London Hospital, London E1 1BB, UK and
1 Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
Correspondence to:
C. G. Barnes, Little Hoopern, Chagford, Devon TQ13 8BZ, UK.
It may be asked why rheumatologists have interested themselves in Behçet's syndrome (BS). The obvious answer must be that BS is a vasculitis and a common feature with which it may present is an inflammatory arthritis. Most papers on BS start with a statement that it is a multi-system inflammatory disease of uncertain aetiology, now classified as a vasculitis. It has been shown to be uncommon in western Europe and the USA, while being much more prevalent in the eastern Mediterranean countries, South East Asia and Japan in particular. Young onset (before the age of 25 yr) and males have been shown to have more severe disease [1, 2]. Although the commonest age of development is in the third decade of life, children may be affected with apparently identical features [3].
It may seem curious that there remains a debate on which terminology,
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. K. Ahn, H.-S. Cha, E.-M. Koh, S.-H. Kim, Y. G. Kim, C.-K. Lee, and B. Yoo Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8 Rheumatology, August 1, 2008; 47(8): 1228 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Calguneri, K. Aydemir, M. A. Ozturk, I. C. Haznedaroglu, S. Kiraz, and I. Ertenli Myocardial Infarction and Deep Venous Thrombosis in a Young Patient with Behcet Disease Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 105 - 109. [Abstract] [PDF]
|
|